Clinical Evaluation of Opto-Acoustic Image Quality With the Gen 2 Imagio System
Launched by SENO MEDICAL INSTRUMENTS INC. · Aug 20, 2021
Trial Information
Current as of July 01, 2025
Completed
Keywords
ClinConnect Summary
1. Obtain ultrasound only probe images and duplex probe OA/US (both gray scale and OA) probe images. This includes doppler and elastography imaging with the gray scale only ultrasound probe and ultrasound mode of the duplex OA/US probe.
2. Provide breast and lymph node pathology results (except BI-RADS 1, 2 and 3 (as applicable))
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Has a signed and dated informed consent, prior to initiation of any study-related activities.
- • 2. Is at least 18 years of age.
- • 3. Have been referred for a breast US because of a breast lesion/mass finding via a palpable lump or per standard of care imaging.
- • 4. Is willing and able to comply with protocol-required scans
- Exclusion Criteria:
- • 1. Is pregnant or lactating.
- • 2. Has a condition or breast impediment (i.e. insect bites, poison ivy, rash, open wounds, chafing of the skin, scar, tattoos, moles, hematoma, nipple rings, etc.) which could interfere with the intended field of view.
- • 3. Is experiencing photo-toxicity associated with currently taking, or having taken, photosensitizing agents within the previous 72 hours such as some sulfur containing drugs, ampicillin, tetracycline.
- • 4. Is currently undergoing phototherapy.
- • 5. Has a history of any photosensitive disease (e.g., porphyria, lupus erythematosus) or undergoing treatment for a photosensitive disease and is experiencing photosensitivity.
- • 6. Has had an adverse reaction in the past to medical laser procedures, such as laser hair removal or laser tattoo removal.
- • 7. Has had prior benign excisional breast biopsy on breast of interest within the past 18 months.
- • 8. Currently has mastitis.
- • 9. Prisoners
About Seno Medical Instruments Inc.
Seno Medical Instruments Inc. is a pioneering medical device company focused on advancing breast imaging technologies to enhance early detection and diagnosis of breast cancer. With a commitment to innovation, the company specializes in developing proprietary ultrasound-based imaging solutions that aim to improve clinical outcomes and patient care. By leveraging cutting-edge technology and rigorous clinical research, Seno Medical Instruments strives to provide healthcare professionals with reliable tools that support informed decision-making in breast health management. Through its dedication to quality and efficacy, the company plays a vital role in the ongoing fight against breast cancer.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
San Antonio, Texas, United States
Patients applied
Trial Officials
Pam Otto, MD
Principal Investigator
UTHSC
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials